ATE70069T1 - Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone. - Google Patents

Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.

Info

Publication number
ATE70069T1
ATE70069T1 AT86117452T AT86117452T ATE70069T1 AT E70069 T1 ATE70069 T1 AT E70069T1 AT 86117452 T AT86117452 T AT 86117452T AT 86117452 T AT86117452 T AT 86117452T AT E70069 T1 ATE70069 T1 AT E70069T1
Authority
AT
Austria
Prior art keywords
antibiotic
factor
aglycon
acylaminoglucuronyl
acylaminoglycuronyl
Prior art date
Application number
AT86117452T
Other languages
English (en)
Inventor
Enrico Selva
Giovanni Cassani
Ernesto Riva
Francesco Parenti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE70069T1 publication Critical patent/ATE70069T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT86117452T 1986-04-11 1986-12-15 Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone. ATE70069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868608809A GB8608809D0 (en) 1986-04-11 1986-04-11 Antibiotic
EP86117452A EP0240609B1 (de) 1986-04-11 1986-12-15 Antibiotika-A40926-N-acylaminoglycuronyl-Aglykone und Antibiotika-A40926-Aglykone

Publications (1)

Publication Number Publication Date
ATE70069T1 true ATE70069T1 (de) 1991-12-15

Family

ID=10596024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86117452T ATE70069T1 (de) 1986-04-11 1986-12-15 Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.

Country Status (22)

Country Link
US (1) US4868171A (de)
EP (1) EP0240609B1 (de)
JP (1) JPH0759593B2 (de)
KR (2) KR950010461B1 (de)
CN (1) CN1033043C (de)
AT (1) ATE70069T1 (de)
AU (1) AU601706B2 (de)
DE (1) DE3682767D1 (de)
DK (1) DK167770B1 (de)
ES (1) ES2040207T3 (de)
FI (1) FI86307C (de)
GB (1) GB8608809D0 (de)
GR (1) GR3003443T3 (de)
HU (1) HU196229B (de)
IE (1) IE59523B1 (de)
IL (1) IL81106A (de)
MY (1) MY101178A (de)
NO (1) NO172121C (de)
NZ (1) NZ218789A (de)
PH (1) PH23620A (de)
PT (1) PT84029B (de)
ZA (1) ZA869713B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
ES2084595T3 (es) * 1988-12-27 1996-05-16 Lepetit Spa Procedimiento quimico mejorado para preparar el antibiotico l/17392 (desglucoteicoplanina) y sus sales.
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
CA2099866C (en) 1991-03-27 2002-07-09 Rolf H. Hermann Antibiotic a 40926 ester derivatives
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
UA41283C2 (uk) * 1991-07-29 2001-09-17 Біосерч Італіа С.П.А. Похідні антибіотику а 40926 та способи їх одержання
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
PT836619E (pt) * 1995-07-05 2004-11-30 Aventis Bulk S P A Purificacao de antibioticos dalba-heptidicos por focagem isoelectrica
CA2250578C (en) 1996-04-23 2003-06-24 Versicor Inc. Improved chemical process for preparing amide derivatives of antibiotic a 40926
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
DK1565201T3 (en) 2002-11-18 2019-02-25 Vicuron Pharmaceuticals Llc METHODS OF ADMINISTRATING DALBAVANCIN TO TREAT Bacterial Infections
CN101851277B (zh) * 2009-03-12 2012-10-03 成都雅途生物技术有限公司 一种道古霉素关键中间体a40926 bo组分的纯化制备方法
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法
CN110105435B (zh) * 2019-05-08 2023-12-08 宜昌东阳光生化制药有限公司 一种生产a40926的发酵培养基和发酵方法
CN112625925B (zh) * 2021-01-08 2022-04-19 浙江大学 一种达巴万星前体a40926b0高产菌株及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO86375B1 (ro) * 1982-03-24 1985-04-01 Eli Lilly And Company Procedeu pentru prepararea antibioticului a 41030
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4521335A (en) * 1983-07-13 1985-06-04 Smithkline Beckman Corporation Aglycone and pseudo-aglycones of the AAD 216 antibiotics
AU579120B2 (en) * 1983-12-16 1988-11-17 Gruppo Lepetit S.P.A. Chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
ES2040207T3 (es) 1993-10-16
IE863382L (en) 1987-10-11
PT84029A (en) 1987-01-01
EP0240609A3 (en) 1988-07-27
MY101178A (en) 1991-07-31
GR3003443T3 (en) 1993-02-17
KR890002231A (ko) 1989-04-08
KR870010194A (ko) 1987-11-30
FI865320A (fi) 1987-10-12
FI865320A0 (fi) 1986-12-29
DK617286A (da) 1987-10-12
GB8608809D0 (en) 1986-05-14
IE59523B1 (en) 1994-03-09
HUT43869A (en) 1987-12-28
IL81106A (en) 1992-07-15
FI86307B (fi) 1992-04-30
NO172121B (no) 1993-03-01
DE3682767D1 (de) 1992-01-16
EP0240609A2 (de) 1987-10-14
PH23620A (en) 1989-09-11
FI86307C (fi) 1992-08-10
US4868171A (en) 1989-09-19
AU6688386A (en) 1987-10-15
EP0240609B1 (de) 1991-12-04
NZ218789A (en) 1990-09-26
PT84029B (pt) 1989-01-17
HU196229B (en) 1988-10-28
KR950010461B1 (ko) 1995-09-18
IL81106A0 (en) 1987-03-31
NO865323L (no) 1987-10-12
KR960010557B1 (ko) 1996-08-02
JPH0759593B2 (ja) 1995-06-28
ZA869713B (en) 1987-12-30
DK167770B1 (da) 1993-12-13
CN1033043C (zh) 1996-10-16
CN86108977A (zh) 1988-04-27
NO172121C (no) 1993-06-09
AU601706B2 (en) 1990-09-20
JPS62242699A (ja) 1987-10-23
DK617286D0 (da) 1986-12-19

Similar Documents

Publication Publication Date Title
ATE70069T1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglyko e und antibiotika-a40926-aglykone.
DE3683266D1 (de) Antibiotikum a 40926 mannosyl aglycon.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DK0451486T3 (da) Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee